GL1X · GenesisL1 explorer

MolNFT v1 · #101418 · protein

Crystal structure of the bromodomain of human BRD9 in complex with a triazolo-phthalazine ligand

4NQN · Bromodomain-containing protein 9: “Crystal structure of the bromodomain of human BRD9 in complex with a triazolo-phthalazine ligand”. X-ray diffraction, 1 ligand (Y1Z), 1 pocket (best druggability 0.50). MolNFT v1 #101418 on…

PDB
4NQN
Type
protein
Length
113 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bromodomain-containing protein 9
UniProt
C9JBY0
Ligands
Y1Z
Pockets
1 · best druggability 0.50

Structure

x-ray diffraction · 1 distinct chain · 62% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABromodomain-containing protein 9protein11362% helix, 0% strandC9JBY0

Ligands and binding sites

  • Y1Z · 2-chloro-N-[5-(3-methyl[1,2,4]triazolo[3,4-a]phthalazin-6-yl)-2-(morpholin-4-yl)phenyl]benzenesulfonamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1780.500.8318Y1Z

Compared structures

  • 4NQN · Crystal Structure of the bromodomain of human BRD9 in complex with a triazolo-phthalazine… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.